Huajin Sinogen Appears at BIO APAC 2021 Asia-Pacific Biomedical Cooperation Summit

Beijing time, the "BIO APAC 2021 Asia-Pacific Biomedical Cooperation Summit" was held in Shanghai. With the theme of "global cooperation, accelerating the pace of new drug listing", the participating enterprises jointly explore the possibility of more cooperation and promote the R & D and innovation of new drugs based on the needs of patients

Huajin Pharmaceuticals attended the summit and reported to the conference the world's first tumor-targeted amino acid metabolic regulation therapy biological products.SGN1 (oncolytic bacteria). During the two-day meeting, Huajin Sinogen held one-on-one talks with a number of multinational pharmaceutical companies and listed pharmaceutical companies to conduct in-depth dialogues on the global clinical and commercial cooperation of SGN1.